Business Context and Reporting Period
This Form 8-K is filed by JATT Acquisition Corp (not Zura Bio Ltd) on April 7, 2022. The report addresses a material restatement of the unaudited interim financial statements for the quarter ended September 30, 2021, originally filed on November 19, 2021.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. Instead, it details accounting adjustments required for the September 30, 2021 period:
- Restatement Driver: Improper accounting for the sale and transfer of limited partnership interests in the sponsor (JATT Ventures, L.P.) to Anchor Investors.
- Impact Areas: Additional offering costs must be allocated to derivative warrant liabilities on the statement of operations. The excess fair value over consideration for the limited partnership interests must be reflected in the statement of changes in stockholders' deficit.
Material Changes Versus Prior Period
The primary material change is the determination that the previously issued September 30, 2021 financial statements are unreliable. The company concluded that the Anchor Investors' incentives were not properly accounted for or disclosed in the original filing. Consequently, the prior financial statements should no longer be relied upon.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Item: A material accounting error regarding the treatment of Anchor Investor incentives and derivative warrant liabilities.
- Internal Controls: Management reassessed disclosure controls and procedures for the affected periods and determined they were not effective solely due to this error.
- Future Filings: The company will file audited financial statements for the year ended December 31, 2021, in its upcoming Form 10-K. An amended Form 10-Q/A for the quarter ended September 30, 2021, will follow shortly thereafter with corrected accounting.
- Auditor Communication: The matter has been discussed with Marcum, LLP, the independent registered public accounting firm.
Investor Verification Checklist
- Verify the upcoming amended Form 10-Q/A for the quarter ended September 30, 2021, to review corrected financial statements.
- Monitor the Form 10-K for the year ended December 31, 2021, for the final audited figures reflecting the restatement.
- Review the specific allocation of offering costs to derivative warrant liabilities in the restated documents.
- Confirm the status of the company's disclosure controls and procedures following the restatement.